image
NeuroBo Pharmaceuticals, Inc. NRBO
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 2.22
-8.64 %
$ 19.1 M
Market Cap
-0.55
P/E
BALANCE SHEET
22.8 M ASSETS
-32.07%
Growth Rates
1Year -32.07%
3Years 27.59%
5Years 2.96%
7Years -1.18%
10Years 0.00%
6.1 M LIABILITIES
-48.27%
Growth Rates
1Year -48.27%
3Years 17.42%
5Years -42.39%
7Years 5.75%
10Years 0.00%
16.7 M EQUITY
-23.29%
Growth Rates
1Year -23.29%
3Years 32.31%
5Years 17.28%
7Years -2.99%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition NeuroBo Pharmaceuticals, Inc.
image
Current Assets 22.5 M
Cash & Short-Term Investments 22.4 M
Receivables 0
Other Current Assets 77 K
Non-Current Assets 269 K
Long-Term Investments 0
PP&E 248 K
Other Non-Current Assets 21 K
Current Liabilities 5.96 M
Accounts Payable 821 K
Short-Term Debt 134 K
Other Current Liabilities 5 M
Non-Current Liabilities 136 K
Long-Term Debt 136 K
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014
ASSETS
Cash & Cash Equivalents 22.4 33.4 16.4 10.1 13.9 19.0 18.5 24.0 3.6 0.3
Short Term Investments 0 0 0 0 0 0 0 0 0 0
Receivables 0 0 0 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0 0
Other Current Assets 77 K 0.2 0.2 0.6 0.2 1.0 0.5 0.7 23 K 13 K
Total Current Assets 22.5 33.5 16.6 10.7 14.1 19.0 19.0 24.7 3.6 0.3
PP&E 0.2 2 K 0.2 0.3 0.3 12 K 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 21 K 0 0 0 0 0.7 8 K 8 K 0.8 0
Other Assets 0 0 0 0 0 0 0 0 0 0
Total Assets 22.8 33.5 16.8 11.0 14.5 19.7 19.0 24.8 4.5 0.3
LIABILITIES
Accounts Payable 0.8 0.7 0.8 2.6 0.6 0.2 4.0 2.0 10 K 21 K
Short Term Debt 0.1 0 52 K 48 K 44 K 9.4 1.4 0 6.4 0.7
Other Current Liabilities 5.0 11.1 1.3 1.1 1.4 (9.4) 1.0 2.1 2.5 0.1
Total Current Liabilities 6.0 11.8 2.2 3.7 2.1 9.4 6.4 4.1 8.9 0.9
Long Term Debt 0.1 0 45 K 70 K 94 K 0.1 8.7 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 86.5 3 K 1 K 8.0 0
Total Liabilities 6.1 11.8 2.2 3.8 2.2 96.0 15.1 4.1 16.9 0.9
EQUITY
Common Stock 5 K 25 K 27 K 20 K 16 K 22 K 18 K 17 K 12 K 9 K
Retained Earnings (108.3) (95.8) (81.8) (66.5) (36.9) (84.1) (60.5) (27.1) (12.4) (0.6)
Other Accumulative Comprehensive Income/Loss 0 0 4 K 14 K 12 K 2 K 0 (24.8) (8.0) 0
Total Equity 16.7 21.8 14.6 7.2 12.3 (76.3) 3.9 20.6 (12.4) (0.5)
Total Liabilities and Equity 22.8 33.5 16.8 11.0 14.5 19.7 19.0 24.8 4.5 0.3
SHARES OUTSTANDING
Common Shares Outstanding 5.1 0.3 96.4 K 67.6 K 21.8 K 0.1 13.8 K 7.74 K 7.07 K 7.07 K